Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Milestone Pharmaceuticals Inc (MIST)
Milestone Pharmaceuticals Inc (MIST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 125,426
  • Shares Outstanding, K 33,358
  • Annual Sales, $ 5,000 K
  • Annual Income, $ -58,390 K
  • 60-Month Beta 2.01
  • Price/Sales 24.68
  • Price/Cash Flow N/A
  • Price/Book 2.43
Trade MIST with:

Options Overview Details

View History
  • Implied Volatility 143.42% ( +81.61%)
  • Historical Volatility 61.20%
  • IV Percentile 72%
  • IV Rank 37.83%
  • IV High 371.27% on 08/10/22
  • IV Low 4.78% on 06/06/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5
  • Volume Avg (30-Day) 77
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 3,122
  • Open Int (30-Day) 4,818

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.39
  • Number of Estimates 5
  • High Estimate -0.37
  • Low Estimate -0.41
  • Prior Year -0.39
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.50 +7.43%
on 05/05/23
4.49 -16.26%
on 05/12/23
+0.25 (+7.12%)
since 05/02/23
3-Month
3.10 +21.29%
on 03/23/23
4.49 -16.26%
on 05/12/23
+0.52 (+16.05%)
since 03/02/23
52-Week
3.10 +21.29%
on 03/23/23
9.85 -61.81%
on 09/20/22
-1.69 (-31.01%)
since 06/02/22

Most Recent Stories

More News
Milestone Pharmaceuticals to Present at the Jefferies Healthcare Conference

/CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

MIST : 3.76 (+1.62%)
Milestone Pharmaceuticals Announces Presentation of Data from Analysis of Etripamil Nasal Spray in Patients Experiencing Atrial Fibrillation with Rapid Ventricular Rate

/CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

MIST : 3.76 (+1.62%)
Milestone Pharmaceuticals Announces Presentation of Data from Analysis of Etripamil Nasal Spray in Patients Experiencing Atrial Fibrillation with Rapid Ventricular Rate

/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

MIST : 3.76 (+1.62%)
Milestone Pharmaceuticals: Q1 Earnings Snapshot

Milestone Pharmaceuticals: Q1 Earnings Snapshot

MIST : 3.76 (+1.62%)
Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update

/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

MIST : 3.76 (+1.62%)
Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update

/CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

MIST : 3.76 (+1.62%)
Milestone Pharmaceuticals to Host Virtual Key Opinion Leader Event on Etripamil for the Treatment of Atrial Fibrillation with Rapid Ventricular Rate

/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

MIST : 3.76 (+1.62%)
Milestone Pharmaceuticals to Host Virtual Key Opinion Leader Event on Etripamil for the Treatment of Atrial Fibrillation with Rapid Ventricular Rate

/CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

MIST : 3.76 (+1.62%)
Milestone Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference

/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

MIST : 3.76 (+1.62%)
Milestone Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference

/CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

MIST : 3.76 (+1.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. The company's lead product candidate consists of MSP-2017, a nasal spray. Milestone Pharmaceuticals...

See More

Key Turning Points

3rd Resistance Point 4.11
2nd Resistance Point 4.02
1st Resistance Point 3.89
Last Price 3.76
1st Support Level 3.66
2nd Support Level 3.57
3rd Support Level 3.44

See More

52-Week High 9.85
Fibonacci 61.8% 7.27
Fibonacci 50% 6.47
Fibonacci 38.2% 5.68
Last Price 3.76
52-Week Low 3.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar